Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma

Recruiting now · Early Phase 1

Conditions studied: Newly Diagnosed Glioblastoma

In brief

Proposed treatment of subjects with newly diagnosed glioblastoma with novel personalized drug regimens identified to be effective in vitro using cancer stem cells derived from their individual tumors, alongside standard of care radiation and TMZ.

Key facts

Study ID
NCT05380349
Run by
Swedish Medical Center
People needed
10
Starts
2024-04-19
Expected to finish
2027-12-01
Last updated by the study team
2025-05-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.